Insights

Loading spinner
Gathering insights about Gabaeron

Similar companies to Gabaeron

Gabaeron Tech Stack

Media & News

Gabaeron's Email Address Formats

Gabaeron uses at least 1 format(s):
Gabaeron Email FormatsExamplePercentage
First.Last@gabaeron.comJohn.Doe@gabaeron.com
100%

Frequently Asked Questions

Where is Gabaeron's headquarters located?

Minus sign iconPlus sign icon
Gabaeron's main headquarters is located at San Francisco, California 94158 United States. The company has employees across 1 continents, including North America.

What is Gabaeron's SIC code NAICS code?

Minus sign iconPlus sign icon
Gabaeron's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Gabaeron have currently?

Minus sign iconPlus sign icon
As of February 2026, Gabaeron has approximately 11 employees across 1 continents, including North America. Key team members include Senior Research Associate, Cell Biology: I. A.. Explore Gabaeron's employee directory with LeadIQ.

What industry does Gabaeron belong to?

Minus sign iconPlus sign icon
Gabaeron operates in the Biotechnology Research industry.

What is Gabaeron's email format?

Minus sign iconPlus sign icon
Gabaeron's email format typically follows the pattern of First.Last@gabaeron.com. Find more Gabaeron email formats with LeadIQ.

How much funding has Gabaeron raised to date?

Minus sign iconPlus sign icon
As of February 2026, Gabaeron has raised $3M in funding. The last funding round occurred on Dec 21, 2024 for $3M.

Gabaeron

Biotechnology ResearchCalifornia, United States11-50 Employees

GABAeron, Inc. is a biopharmaceutical company focusing on the development of therapies using stem cells and small molecules to treat neurological diseases. GABAeron takes a novel approach that combines precision medicine (using genetic information for patient stratification) with regenerative medicine (using human iPSC-derived cell products for therapy) and pharmacological intervention (small molecules). The therapeutic programs of GABAeron are specifically designed to replace or protect some of the most vulnerable brain cell populations to restore and preserve brain functions with human iPSC-derived cell products and small molecules in patients with genetically defined neurological diseases. 

We are hiring! 

https://www.biospace.com/employer/1857660/gabaeron/?PageListType=1#lister

Section iconCompany Overview

Headquarters
San Francisco, California 94158 United States
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $3M

    Gabaeron has raised a total of $3M of funding over 1 rounds. Their latest funding round was raised on Dec 21, 2024 in the amount of $3M.

  • $1M$10M

    Gabaeron's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $3M

    Gabaeron has raised a total of $3M of funding over 1 rounds. Their latest funding round was raised on Dec 21, 2024 in the amount of $3M.

  • $1M$10M

    Gabaeron's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.